Tarsus Pharmaceuticals, Inc.

TARS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$112,724$96,648$175,787$94,819
Short-Term Investments$289,113$284,495$232,129$196,557
Receivables$74,336$60,240$64,153$48,059
Inventory$3,836$3,873$2,705$2,620
Other Curr. Assets$21,695$29,173$5,999$14,650
Total Curr. Assets$501,704$474,429$480,773$356,705
Property Plant & Equip (Net)$15,979$3,411$3,180$2,866
Goodwill$0$0$0$0
Intangibles$7,606$7,846$8,086$8,326
Long-Term Investments$5,563$3,000$3,000$3,000
Tax Assets$0$0$0$0
Other NC Assets$3,709$6,308$5,711$6,094
Total NC Assets$32,857$20,565$19,977$20,286
Other Assets$0$0$0$0
Total Assets$534,561$494,994$500,750$376,991
Liabilities
Payables$40,642$28,075$28,383$27,739
Short-Term Debt$80$317$384$608
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$76,328$61,861$57,541$52,265
Total Curr. Liab.$117,050$90,253$86,308$80,612
LT Debt$82,429$72,129$71,984$71,845
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$82,429$72,129$71,984$71,845
Other Liabilities$0$0$0$0
Cap. Leases$10,148$317$384$608
Total Liabilities$199,479$162,382$158,292$152,457
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$418,255-$405,670-$385,330-$360,210
AOCI$289$39$85$179
Other Equity$753,042$738,237$727,697$584,559
Total Equity$335,082$332,612$342,458$224,534
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$534,561$494,994$500,750$376,991
Net Debt-$30,215-$24,202-$103,419-$22,366
Tarsus Pharmaceuticals, Inc. (TARS) Financial Statements & Key Stats | AlphaPilot